Therefore, our finding is potentially important from a clinical point of view, given the increasing body of evidence on efficacy for TMZ‐based regimens in MGMT‐methylated gastrointestinal tumors and especially colorectal cancer [19, 20, 33, 34]. The gene discussed is MGMT; the disease is colorectal cancer.